Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.

Identifieur interne : 003483 ( PubMed/Curation ); précédent : 003482; suivant : 003484

Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.

Auteurs : C A De Haan [Pays-Bas] ; M. Smeets ; F. Vernooij ; H. Vennema ; P J Rottier

Source :

RBID : pubmed:10438834

Descripteurs français

English descriptors

Abstract

The coronavirus membrane (M) protein is the key player in virion assembly. One of its functions is to mediate the incorporation of the spikes into the viral envelope. Heterotypic interactions between M and the spike (S) protein can be demonstrated by coimmunoprecipitation and by immunofluorescence colocalization, after coexpression of their genes in eukaryotic cells. Using these assays in a mutagenetic approach, we have mapped the domains in the M protein that are involved in complex formation between M and S. It appeared that the 25-residue luminally exposed amino-terminal domain of the M protein is not important for M-S interaction. A 15-residue deletion, the insertion of a His tag, and replacement of the ectodomain by that of another coronavirus M protein did not affect the ability of the M protein to associate with the S protein. However, complex formation was sensitive to changes in the transmembrane domains of this triple-spanning protein. Deletion of either the first two or the last two transmembrane domains, known not to affect the topology of the protein, led to a considerable decrease in complex formation, but association was not completely abrogated. Various effects of changes in the part of the M protein that is located at the cytoplasmic face of the membrane were observed. Deletions of the extreme carboxy-terminal tail appeared not to interfere with M-S complex formation. However, deletions in the amphipathic domain severely affected M-S interaction. Interestingly, changes in the amino-terminal and extreme carboxy-terminal domains of M, which did not disrupt the interaction with S, are known to be fatal to the ability of the protein to engage in virus particle formation (C. A. M. de Haan, L. Kuo, P. S. Masters, H. Vennema, and P. J. M. Rottier, J. Virol. 72:6838-6850, 1998). Apparently, the structural requirements of the M protein for virus particle assembly differ from the requirements for the formation of M-S complexes.

PubMed: 10438834

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:10438834

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.</title>
<author>
<name sortKey="De Haan, C A" sort="De Haan, C A" uniqKey="De Haan C" first="C A" last="De Haan">C A De Haan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Institute of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Institute of Biomembranes, Utrecht University, Utrecht</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Smeets, M" sort="Smeets, M" uniqKey="Smeets M" first="M" last="Smeets">M. Smeets</name>
</author>
<author>
<name sortKey="Vernooij, F" sort="Vernooij, F" uniqKey="Vernooij F" first="F" last="Vernooij">F. Vernooij</name>
</author>
<author>
<name sortKey="Vennema, H" sort="Vennema, H" uniqKey="Vennema H" first="H" last="Vennema">H. Vennema</name>
</author>
<author>
<name sortKey="Rottier, P J" sort="Rottier, P J" uniqKey="Rottier P" first="P J" last="Rottier">P J Rottier</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10438834</idno>
<idno type="pmid">10438834</idno>
<idno type="wicri:Area/PubMed/Corpus">003483</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003483</idno>
<idno type="wicri:Area/PubMed/Curation">003483</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003483</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.</title>
<author>
<name sortKey="De Haan, C A" sort="De Haan, C A" uniqKey="De Haan C" first="C A" last="De Haan">C A De Haan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Institute of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Institute of Biomembranes, Utrecht University, Utrecht</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Smeets, M" sort="Smeets, M" uniqKey="Smeets M" first="M" last="Smeets">M. Smeets</name>
</author>
<author>
<name sortKey="Vernooij, F" sort="Vernooij, F" uniqKey="Vernooij F" first="F" last="Vernooij">F. Vernooij</name>
</author>
<author>
<name sortKey="Vennema, H" sort="Vennema, H" uniqKey="Vennema H" first="H" last="Vennema">H. Vennema</name>
</author>
<author>
<name sortKey="Rottier, P J" sort="Rottier, P J" uniqKey="Rottier P" first="P J" last="Rottier">P J Rottier</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Binding Sites</term>
<term>Cats</term>
<term>Cell Line</term>
<term>Cell Membrane (metabolism)</term>
<term>Chromosome Mapping</term>
<term>Cricetinae</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Murine hepatitis virus (genetics)</term>
<term>Murine hepatitis virus (metabolism)</term>
<term>Mutagenesis</term>
<term>Precipitin Tests</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (metabolism)</term>
<term>Viral Matrix Proteins (genetics)</term>
<term>Viral Matrix Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cartographie chromosomique</term>
<term>Chats</term>
<term>Cricetinae</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Mutagenèse</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Protéines de la matrice virale (génétique)</term>
<term>Protéines de la matrice virale (métabolisme)</term>
<term>Sites de fixation</term>
<term>Tests aux précipitines</term>
<term>Virus de l'hépatite murine (génétique)</term>
<term>Virus de l'hépatite murine (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines de la matrice virale</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cell Membrane</term>
<term>Membrane Glycoproteins</term>
<term>Murine hepatitis virus</term>
<term>Viral Envelope Proteins</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Membrane cellulaire</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines de la matrice virale</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Binding Sites</term>
<term>Cats</term>
<term>Cell Line</term>
<term>Chromosome Mapping</term>
<term>Cricetinae</term>
<term>Mutagenesis</term>
<term>Precipitin Tests</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cartographie chromosomique</term>
<term>Chats</term>
<term>Cricetinae</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Lignée cellulaire</term>
<term>Mutagenèse</term>
<term>Sites de fixation</term>
<term>Tests aux précipitines</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The coronavirus membrane (M) protein is the key player in virion assembly. One of its functions is to mediate the incorporation of the spikes into the viral envelope. Heterotypic interactions between M and the spike (S) protein can be demonstrated by coimmunoprecipitation and by immunofluorescence colocalization, after coexpression of their genes in eukaryotic cells. Using these assays in a mutagenetic approach, we have mapped the domains in the M protein that are involved in complex formation between M and S. It appeared that the 25-residue luminally exposed amino-terminal domain of the M protein is not important for M-S interaction. A 15-residue deletion, the insertion of a His tag, and replacement of the ectodomain by that of another coronavirus M protein did not affect the ability of the M protein to associate with the S protein. However, complex formation was sensitive to changes in the transmembrane domains of this triple-spanning protein. Deletion of either the first two or the last two transmembrane domains, known not to affect the topology of the protein, led to a considerable decrease in complex formation, but association was not completely abrogated. Various effects of changes in the part of the M protein that is located at the cytoplasmic face of the membrane were observed. Deletions of the extreme carboxy-terminal tail appeared not to interfere with M-S complex formation. However, deletions in the amphipathic domain severely affected M-S interaction. Interestingly, changes in the amino-terminal and extreme carboxy-terminal domains of M, which did not disrupt the interaction with S, are known to be fatal to the ability of the protein to engage in virus particle formation (C. A. M. de Haan, L. Kuo, P. S. Masters, H. Vennema, and P. J. M. Rottier, J. Virol. 72:6838-6850, 1998). Apparently, the structural requirements of the M protein for virus particle assembly differ from the requirements for the formation of M-S complexes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">10438834</PMID>
<DateCompleted>
<Year>1999</Year>
<Month>09</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>73</Volume>
<Issue>9</Issue>
<PubDate>
<Year>1999</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.</ArticleTitle>
<Pagination>
<MedlinePgn>7441-52</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The coronavirus membrane (M) protein is the key player in virion assembly. One of its functions is to mediate the incorporation of the spikes into the viral envelope. Heterotypic interactions between M and the spike (S) protein can be demonstrated by coimmunoprecipitation and by immunofluorescence colocalization, after coexpression of their genes in eukaryotic cells. Using these assays in a mutagenetic approach, we have mapped the domains in the M protein that are involved in complex formation between M and S. It appeared that the 25-residue luminally exposed amino-terminal domain of the M protein is not important for M-S interaction. A 15-residue deletion, the insertion of a His tag, and replacement of the ectodomain by that of another coronavirus M protein did not affect the ability of the M protein to associate with the S protein. However, complex formation was sensitive to changes in the transmembrane domains of this triple-spanning protein. Deletion of either the first two or the last two transmembrane domains, known not to affect the topology of the protein, led to a considerable decrease in complex formation, but association was not completely abrogated. Various effects of changes in the part of the M protein that is located at the cytoplasmic face of the membrane were observed. Deletions of the extreme carboxy-terminal tail appeared not to interfere with M-S complex formation. However, deletions in the amphipathic domain severely affected M-S interaction. Interestingly, changes in the amino-terminal and extreme carboxy-terminal domains of M, which did not disrupt the interaction with S, are known to be fatal to the ability of the protein to engage in virus particle formation (C. A. M. de Haan, L. Kuo, P. S. Masters, H. Vennema, and P. J. M. Rottier, J. Virol. 72:6838-6850, 1998). Apparently, the structural requirements of the M protein for virus particle assembly differ from the requirements for the formation of M-S complexes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de Haan</LastName>
<ForeName>C A</ForeName>
<Initials>CA</Initials>
<AffiliationInfo>
<Affiliation>Institute of Virology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smeets</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vernooij</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vennema</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rottier</LastName>
<ForeName>P J</ForeName>
<Initials>PJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>108502-71-2</RegistryNumber>
<NameOfSubstance UI="C067997">M protein, Coronavirus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006517" MajorTopicYN="N">Murine hepatitis virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016296" MajorTopicYN="N">Mutagenesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1999</Year>
<Month>8</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1999</Year>
<Month>8</Month>
<Day>10</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1999</Year>
<Month>8</Month>
<Day>10</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">10438834</ArticleId>
<ArticleId IdType="pmc">PMC104271</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1981 Nov;40(2):350-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6275093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1981 Dec;115(2):334-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7314449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1988 May;106(5):1475-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2836431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1988 Oct 15;263(29):14956-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2844793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1989 Mar;169(1):233-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2538034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1990 Jun;64(6):3051-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1692350</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1991 Mar;181(1):327-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1847259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Exp Med Biol. 1990;276:127-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1966403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1991 Sep 5;266(25):16876-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1885615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene. 1991 Dec 15;108(2):201-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1660838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1992 Jul 15;267(20):14094-101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1629209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1992 Oct 25;267(30):21911-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1400501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1992 Oct;73 ( Pt 10):2731-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1402806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1992 Nov;66(11):6294-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1328669</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1994 Jan;124(1-2):55-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8294506</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1994 Oct;68(10):6523-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8083990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1995 Apr 14;270(15):8815-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7721788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1995 Aug 28;371(1):9-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7664891</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1995 Oct;131(2):339-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7593163</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1996 Feb 15;216(2):289-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8607258</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8617249</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1996 Apr 1;218(1):52-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8615041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1996 Jul;70(7):4773-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8676505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 1995 Dec;39(2-3):261-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8837889</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Feb;71(2):949-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8995612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Dec;71(12):9278-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9371586</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Aug;72(8):6838-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9658133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Oct;72(10):7885-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9733825</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1998 Nov 6;273(45):29905-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9792708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Mol Biol Rev. 1998 Dec;62(4):1171-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9841669</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1980 Jan;33(1):449-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6245243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1982 Dec;44(3):804-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6294330</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003483 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003483 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:10438834
   |texte=   Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:10438834" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021